Device, Vascular, For Promoting Embolization
Main Filters
Device, Vascular, For Promoting Embolization
| IMBiotechnologies Ltd | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| Ekobi 501 | 0 | - | ||
| Ekobi 502 | 0 | - | ||
| Ekobi 503 | 0 | - | ||
| Ekobi 503L | 0 | - | ||
| Ekobi 503P | 0 | - | ||
| Ekobi 504 | 0 | - | ||
| Ekobi 505 | 0 | - | ||
| Shanghai Wallaby Medical Technologies Co., Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 10USH05006 | 0 | - | ||
| 10USH05008 | 0 | - | ||
| 10USH05010 | 0 | - | ||
| Stryker Corporation | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 542206 | 0 | - | ||
| 542410 | 0 | - | ||
| 544203 | 0 | - | ||
| 544204 | 0 | - | ||
| 544254 | 0 | - | ||
| 544304 | 0 | - | ||
| 544306 | 0 | - | ||
| 544356 | 0 | - | ||
| 545202 | 0 | - | ||
| 545203 | 0 | - | ||
| 545204 | 0 | - | ||
| 545206 | 0 | - | ||
| 545253 | 0 | - | ||
| 545254 | 0 | - | ||
| 545256 | 0 | - | ||
| 545304 | 0 | - | ||
| 545306 | 0 | - | ||
| 545308 | 0 | - | ||
| 546113 | 0 | - | ||
| 546123 | 0 | - | ||
| 546133 | 0 | - | ||
| 546143 | 0 | - | ||
| 546154 | 0 | - | ||
| 546306 | 0 | - | ||
| 546308 | 0 | - | ||
| 546415 | 0 | - | ||
| 546520 | 0 | - | ||
| 546630 | 0 | - | ||
| 546715 | 0 | - | ||
| 546920 | 0 | - | ||
| 547103 | 0 | - | ||
| 547113 | 0 | - | ||
| 547123 | 0 | - | ||
| 547133 | 0 | - | ||
| 547143 | 0 | - | ||
| 547204 | 0 | - | ||
| 547310 | 0 | - | ||
| 547410 | 0 | - | ||
| 611104 | 0 | - | ||
| 615825 | 0 | - | ||
5,525 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.